BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33729700)

  • 21. Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.
    Wu J; Cai J
    Dig Dis Sci; 2021 Feb; 66(2):359-368. PubMed ID: 32140943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic cancer: diagnosis and treatments.
    Li HY; Cui ZM; Chen J; Guo XZ; Li YY
    Tumour Biol; 2015 Mar; 36(3):1375-84. PubMed ID: 25680410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in early diagnosis and therapy of pancreatic cancer.
    Xu Q; Zhang TP; Zhao YP
    Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):128-35. PubMed ID: 21459718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
    Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
    J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer.
    Haller SD; Monaco ML; Essani K
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33213031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
    Amedei A; Niccolai E; Prisco D
    Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice.
    Sarkar D; Su ZZ; Vozhilla N; Park ES; Randolph A; Valerie K; Fisher PB
    Cancer Res; 2005 Oct; 65(19):9056-63. PubMed ID: 16204080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination Immunotherapy Approaches for Pancreatic Cancer Treatment.
    Cheng X; Zhao G; Zhao Y
    Can J Gastroenterol Hepatol; 2018; 2018():6240467. PubMed ID: 29707526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Landmark Series: Immunotherapy and Targeted Therapy for Pancreatic Cancer.
    Rocha FG
    Ann Surg Oncol; 2021 Mar; 28(3):1400-1406. PubMed ID: 33386541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic cancer: from molecular pathogenesis to targeted therapy.
    Strimpakos A; Saif MW; Syrigos KN
    Cancer Metastasis Rev; 2008 Sep; 27(3):495-522. PubMed ID: 18427734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the management of pancreatic adenocarcinoma.
    Karakas Y; Lacin S; Yalcin S
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):51-62. PubMed ID: 29125367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular therapy in pancreatic adenocarcinoma.
    MacKenzie MJ
    Lancet Oncol; 2004 Sep; 5(9):541-9. PubMed ID: 15337483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell optimization for the treatment of pancreatic cancer.
    Liu F; Saif MW
    Expert Opin Biol Ther; 2017 Dec; 17(12):1493-1501. PubMed ID: 28835191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newer Trends in Pancreatic Cancer Treatment: Genetic Alterations and the Role of Immune Therapeutic and Targeted Therapies.
    Hussain I; Rashid MU; Sarvepalli D; Rahman AU; Ullah W; Badar H; Jehanzeb S; Khan AK; Khan MT; Muzammil M; Ahmad S
    Crit Rev Oncog; 2019; 24(2):157-177. PubMed ID: 31679211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy for pancreatic cancer.
    Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
    Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic resistance of pancreatic cancer: Roadmap to its reversal.
    Yu S; Zhang C; Xie KP
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188461. PubMed ID: 33157162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New targeted therapies in pancreatic cancer.
    Seicean A; Petrusel L; Seicean R
    World J Gastroenterol; 2015 May; 21(20):6127-45. PubMed ID: 26034349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current developments, problems and solutions in the non-surgical treatment of pancreatic cancer.
    Guo XZ; Cui ZM; Liu X
    World J Gastrointest Oncol; 2013 Feb; 5(2):20-8. PubMed ID: 23556053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel.
    Brouwer TP; Vahrmeijer AL; de Miranda NFCC
    Cell Oncol (Dordr); 2021 Apr; 44(2):261-278. PubMed ID: 33710604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.